785957003: Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...

\Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Dopa decarboxylase inhibitor-containing product\Carbidopa-containing product\Carbidopa-containing product in oral dose form\Carbidopa- and levodopa-containing product in oral dose form\Carbidopa- and entacapone- and levodopa-containing product in oral dose form\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Dopa decarboxylase inhibitor-containing product\Carbidopa-containing product\Carbidopa- and levodopa-containing product\Carbidopa- and levodopa-containing product in oral dose form\Carbidopa- and entacapone- and levodopa-containing product in oral dose form\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Dopa decarboxylase inhibitor-containing product\Carbidopa-containing product\Carbidopa- and levodopa-containing product\Carbidopa- and entacapone- and levodopa-containing product\Carbidopa and entacapone and levodopa only product\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Dopa decarboxylase inhibitor-containing product\Carbidopa-containing product\Carbidopa- and levodopa-containing product\Carbidopa- and entacapone- and levodopa-containing product\Carbidopa- and entacapone- and levodopa-containing product in oral dose form\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Transferase inhibitor-containing product\Methyltransferase inhibitor-containing product\Catechol-O-methyltransferase inhibitor-containing product\Entacapone-containing product\Entacapone-containing product in oral dose form\Carbidopa- and entacapone- and levodopa-containing product in oral dose form\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Transferase inhibitor-containing product\Methyltransferase inhibitor-containing product\Catechol-O-methyltransferase inhibitor-containing product\Entacapone-containing product\Carbidopa- and entacapone- and levodopa-containing product\Carbidopa and entacapone and levodopa only product\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Transferase inhibitor-containing product\Methyltransferase inhibitor-containing product\Catechol-O-methyltransferase inhibitor-containing product\Entacapone-containing product\Carbidopa- and entacapone- and levodopa-containing product\Carbidopa- and entacapone- and levodopa-containing product in oral dose form\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Medicinal product categorised by disposition\Dopamine receptor agonist-containing product\Carbidopa-containing product\Carbidopa-containing product in oral dose form\Carbidopa- and levodopa-containing product in oral dose form\Carbidopa- and entacapone- and levodopa-containing product in oral dose form\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Medicinal product categorised by disposition\Dopamine receptor agonist-containing product\Carbidopa-containing product\Carbidopa- and levodopa-containing product\Carbidopa- and levodopa-containing product in oral dose form\Carbidopa- and entacapone- and levodopa-containing product in oral dose form\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Medicinal product categorised by disposition\Dopamine receptor agonist-containing product\Carbidopa-containing product\Carbidopa- and levodopa-containing product\Carbidopa- and entacapone- and levodopa-containing product\Carbidopa and entacapone and levodopa only product\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Medicinal product categorised by disposition\Dopamine receptor agonist-containing product\Carbidopa-containing product\Carbidopa- and levodopa-containing product\Carbidopa- and entacapone- and levodopa-containing product\Carbidopa- and entacapone- and levodopa-containing product in oral dose form\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Medicinal product categorised by disposition\Dopamine receptor agonist-containing product\Levodopa-containing product\Levodopa-containing product in oral dose form\Carbidopa- and levodopa-containing product in oral dose form\Carbidopa- and entacapone- and levodopa-containing product in oral dose form\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Medicinal product categorised by disposition\Dopamine receptor agonist-containing product\Levodopa-containing product\Carbidopa- and levodopa-containing product\Carbidopa- and levodopa-containing product in oral dose form\Carbidopa- and entacapone- and levodopa-containing product in oral dose form\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Medicinal product categorised by disposition\Dopamine receptor agonist-containing product\Levodopa-containing product\Carbidopa- and levodopa-containing product\Carbidopa- and entacapone- and levodopa-containing product\Carbidopa and entacapone and levodopa only product\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Medicinal product categorised by disposition\Dopamine receptor agonist-containing product\Levodopa-containing product\Carbidopa- and levodopa-containing product\Carbidopa- and entacapone- and levodopa-containing product\Carbidopa- and entacapone- and levodopa-containing product in oral dose form\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet

\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Catecholamine-containing product\Carbidopa-containing product\Carbidopa-containing product in oral dose form\Carbidopa- and levodopa-containing product in oral dose form\Carbidopa- and entacapone- and levodopa-containing product in oral dose form\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Catecholamine-containing product\Carbidopa-containing product\Carbidopa- and levodopa-containing product\Carbidopa- and levodopa-containing product in oral dose form\Carbidopa- and entacapone- and levodopa-containing product in oral dose form\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Catecholamine-containing product\Carbidopa-containing product\Carbidopa- and levodopa-containing product\Carbidopa- and entacapone- and levodopa-containing product\Carbidopa and entacapone and levodopa only product\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Catecholamine-containing product\Carbidopa-containing product\Carbidopa- and levodopa-containing product\Carbidopa- and entacapone- and levodopa-containing product\Carbidopa- and entacapone- and levodopa-containing product in oral dose form\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Catecholamine-containing product\Levodopa-containing product\Levodopa-containing product in oral dose form\Carbidopa- and levodopa-containing product in oral dose form\Carbidopa- and entacapone- and levodopa-containing product in oral dose form\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Catecholamine-containing product\Levodopa-containing product\Carbidopa- and levodopa-containing product\Carbidopa- and levodopa-containing product in oral dose form\Carbidopa- and entacapone- and levodopa-containing product in oral dose form\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Catecholamine-containing product\Levodopa-containing product\Carbidopa- and levodopa-containing product\Carbidopa- and entacapone- and levodopa-containing product\Carbidopa and entacapone and levodopa only product\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Catecholamine-containing product\Levodopa-containing product\Carbidopa- and levodopa-containing product\Carbidopa- and entacapone- and levodopa-containing product\Carbidopa- and entacapone- and levodopa-containing product in oral dose form\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Entacapone-containing product\Entacapone-containing product in oral dose form\Carbidopa- and entacapone- and levodopa-containing product in oral dose form\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Entacapone-containing product\Carbidopa- and entacapone- and levodopa-containing product\Carbidopa and entacapone and levodopa only product\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Entacapone-containing product\Carbidopa- and entacapone- and levodopa-containing product\Carbidopa- and entacapone- and levodopa-containing product in oral dose form\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Medicinal product categorised by structure\Phenol structure-containing product\Entacapone-containing product\Entacapone-containing product in oral dose form\Carbidopa- and entacapone- and levodopa-containing product in oral dose form\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Medicinal product categorised by structure\Phenol structure-containing product\Entacapone-containing product\Carbidopa- and entacapone- and levodopa-containing product\Carbidopa and entacapone and levodopa only product\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Medicinal product categorised by structure\Phenol structure-containing product\Entacapone-containing product\Carbidopa- and entacapone- and levodopa-containing product\Carbidopa- and entacapone- and levodopa-containing product in oral dose form\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet

\Medicinal product categorised by therapeutic role\Antiparkinson agent\...

\Carbidopa-containing product\Carbidopa-containing product in oral dose form\Carbidopa- and levodopa-containing product in oral dose form\Carbidopa- and entacapone- and levodopa-containing product in oral dose form\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Carbidopa-containing product\Carbidopa- and levodopa-containing product\Carbidopa- and levodopa-containing product in oral dose form\Carbidopa- and entacapone- and levodopa-containing product in oral dose form\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Carbidopa-containing product\Carbidopa- and levodopa-containing product\Carbidopa- and entacapone- and levodopa-containing product\Carbidopa and entacapone and levodopa only product\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Carbidopa-containing product\Carbidopa- and levodopa-containing product\Carbidopa- and entacapone- and levodopa-containing product\Carbidopa- and entacapone- and levodopa-containing product in oral dose form\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet

\Entacapone-containing product\Entacapone-containing product in oral dose form\Carbidopa- and entacapone- and levodopa-containing product in oral dose form\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Entacapone-containing product\Carbidopa- and entacapone- and levodopa-containing product\Carbidopa and entacapone and levodopa only product\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Entacapone-containing product\Carbidopa- and entacapone- and levodopa-containing product\Carbidopa- and entacapone- and levodopa-containing product in oral dose form\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet

\Levodopa-containing product\Levodopa-containing product in oral dose form\Carbidopa- and levodopa-containing product in oral dose form\Carbidopa- and entacapone- and levodopa-containing product in oral dose form\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Levodopa-containing product\Carbidopa- and levodopa-containing product\Carbidopa- and levodopa-containing product in oral dose form\Carbidopa- and entacapone- and levodopa-containing product in oral dose form\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Levodopa-containing product\Carbidopa- and levodopa-containing product\Carbidopa- and entacapone- and levodopa-containing product\Carbidopa and entacapone and levodopa only product\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Levodopa-containing product\Carbidopa- and levodopa-containing product\Carbidopa- and entacapone- and levodopa-containing product\Carbidopa- and entacapone- and levodopa-containing product in oral dose form\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet

\Product manufactured as oral dose form\Levodopa-containing product in oral dose form\Carbidopa- and levodopa-containing product in oral dose form\Carbidopa- and entacapone- and levodopa-containing product in oral dose form\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Product manufactured as oral dose form\Entacapone-containing product in oral dose form\Carbidopa- and entacapone- and levodopa-containing product in oral dose form\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
\Product manufactured as oral dose form\Carbidopa-containing product in oral dose form\Carbidopa- and levodopa-containing product in oral dose form\Carbidopa- and entacapone- and levodopa-containing product in oral dose form\Carbidopa and entacapone and levodopa only product in oral dose form\Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet

Status: current, Defined. Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3769833013 Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet en Synonym Active Case insensitive SNOMED CT core

3769834019 Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Case insensitive SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	Has presentation strength numerator unit	mg	true	Inferred relationship	Some	1
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	Is a	Carbidopa and entacapone and levodopa only product in oral dose form	true	Inferred relationship	Some
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	Has precise active ingredient	Entacapone	true	Inferred relationship	Some	1
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	Has presentation strength numerator unit	mg	true	Inferred relationship	Some	2
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	Has presentation strength numerator value	200	false	Inferred relationship	Some	1
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	Has presentation strength denominator value	1	false	Inferred relationship	Some	3
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	Has presentation strength denominator value	1	false	Inferred relationship	Some	2
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	Has presentation strength denominator unit	Tablet	true	Inferred relationship	Some	3
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	Count of base of active ingredient	3	false	Inferred relationship	Some
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	Has presentation strength numerator unit	mg	true	Inferred relationship	Some	3
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	Has presentation strength denominator value	1	false	Inferred relationship	Some	1
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	Has unit of presentation	Tablet	true	Inferred relationship	Some
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	Has presentation strength denominator unit	Tablet	true	Inferred relationship	Some	2
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Some
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	Has presentation strength denominator unit	Tablet	true	Inferred relationship	Some	1
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	Has BoSS	Entacapone	true	Inferred relationship	Some	1
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	Has presentation strength numerator value	31.25	false	Inferred relationship	Some	3
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	Has presentation strength numerator value	125	false	Inferred relationship	Some	2
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	Has precise active ingredient	Levodopa	true	Inferred relationship	Some	2
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	Has precise active ingredient	Carbidopa	true	Inferred relationship	Some	3
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	Has BoSS	Levodopa	true	Inferred relationship	Some	2
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	Has BoSS	Carbidopa anhydrous	true	Inferred relationship	Some	3
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	Plays role	Antiparkinson therapeutic role	true	Inferred relationship	Some

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

Reference Sets

Description inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3769833013	Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	en	Synonym	Active	Case insensitive	SNOMED CT core
3769834019	Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)	en	Fully specified name	Active	Case insensitive	SNOMED CT core